TMI is developing the POINT-GUARD™ Cerebral Embolic Protection to address the devastating & costly problem of stroke during cardiovascular procedures.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free